Tafamidis Treatment for Patients with Transthyretin Amyloid Cardiomyopathy
Tafamidis Treatment for Patients with Transthyretin Amyloid Cardiomyopathy is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Tafamidis Treatment for Patients with Transthyretin Amyloid Cardiomyopathy have?
Tafamidis Treatment for Patients with Transthyretin Amyloid Cardiomyopathy has 2,771 citations in the OpenAlex counts ScholarIQ stores.
When was Tafamidis Treatment for Patients with Transthyretin Amyloid Cardiomyopathy published?
Tafamidis Treatment for Patients with Transthyretin Amyloid Cardiomyopathy has 2018 year in the ScholarIQ index.
What is the open-access status of Tafamidis Treatment for Patients with Transthyretin Amyloid Cardiomyopathy?
Tafamidis Treatment for Patients with Transthyretin Amyloid Cardiomyopathy has bronze oa status in the ScholarIQ index.
What is the DOI of Tafamidis Treatment for Patients with Transthyretin Amyloid Cardiomyopathy?
The DOI for Tafamidis Treatment for Patients with Transthyretin Amyloid Cardiomyopathy is on the source record.
What is the PMID of Tafamidis Treatment for Patients with Transthyretin Amyloid Cardiomyopathy?
The PMID for Tafamidis Treatment for Patients with Transthyretin Amyloid Cardiomyopathy is on the source record.
What is the OpenAlex record for Tafamidis Treatment for Patients with Transthyretin Amyloid Cardiomyopathy?
The OpenAlex for Tafamidis Treatment for Patients with Transthyretin Amyloid Cardiomyopathy is on the source record.